NCT05831865View on ClinicalTrials.gov

Frontline of ASCT in High-risk DLBCL

RecruitingOBSERVATIONAL

Enrollment

175

Participants

Timeline

Start Date

May 3, 2023

Primary Completion Date

April 27, 2025

Study Completion Date

April 27, 2027

Conditions

Diffuse Large B Cell Lymphoma

Trial Locations (1)

010

RECRUITING

Peking University People's Hospital, Beijing

All Listed Sponsors

collaborator

Peking University Cancer Hospital & Institute

OTHER

lead

Peking University People's Hospital

OTHER